Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Sesen Throws in the Towel

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jul 19, 2022 5:07pm

218 Views

Post# 34835568

RE:RE:Sesen Throws in the Towel

August 2021, almost 1y ago, SESN was trading @4.20$US (800M$US in market valuation), so 13.5x TLT's current valuation (58M$US).

It is now worth 128M$US. So 2.2x TLT's current valuation (58M$US). They only have Head&Neck as an indication (https://sesenbio.com/our-programs/).

Sesen Bio (SESN) - Market capitalization

They had a nice graphic by the way on the road to NMIBC
BCG-Unresponsive https://sesenbio.com/patients/

____________________

Eoganacht - (7/19/2022 3:42:23 PM)
RE:Sesen Throws in the Towel

Their stock price dropped from 90 cents on Friday to 62 cents yesterday.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages